BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 24587637)

  • 1. Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.
    Zhao JB; Feng C; Zhu QH; He XF; Li YH; Chen Y
    World J Gastroenterol; 2014 Feb; 20(6):1602-7. PubMed ID: 24587637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Qiu B; Li K; Dong X; Liu FQ
    Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1372-1382. PubMed ID: 28488102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
    Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.
    Hausegger KA; Karnel F; Georgieva B; Tauss J; Portugaller H; Deutschmann H; Berghold A
    J Vasc Interv Radiol; 2004 Mar; 15(3):239-48. PubMed ID: 15028808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis.
    Jiang ZB; Shan H; Shen XY; Huang MS; Li ZR; Zhu KS; Guan SH
    World J Gastroenterol; 2004 Jul; 10(13):1881-4. PubMed ID: 15222028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
    Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
    Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma.
    Fanelli F; Angeloni S; Salvatori FM; Marzano C; Boatta E; Merli M; Rossi P; Attili AF; Ridola L; Cerini F; Riggio O
    Dig Liver Dis; 2011 Jan; 43(1):78-84. PubMed ID: 20637712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients.
    Qi X; Han G; Yin Z; He C; Wang J; Guo W; Niu J; Zhang W; Bai M; Fan D
    Dig Dis Sci; 2012 Apr; 57(4):1072-82. PubMed ID: 22147244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
    Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
    [No Abstract]   [Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation.
    Senzolo M; Tibbals J; Cholongitas E; Triantos CK; Burroughs AK; Patch D
    Aliment Pharmacol Ther; 2006 Mar; 23(6):767-75. PubMed ID: 16556179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation exposure during transjugular intrahepatic portosystemic shunt creation in patients with complete portal vein thrombosis or portal cavernoma.
    Miraglia R; Maruzzelli L; Cannataci C; Gerasia R; Mamone G; Cortis K; Cimò B; Petridis I; Volpes R; Luca A
    Radiol Med; 2020 Jul; 125(7):609-617. PubMed ID: 32072390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.
    Perarnau JM; Le Gouge A; Nicolas C; d'Alteroche L; Borentain P; Saliba F; Minello A; Anty R; Chagneau-Derrode C; Bernard PH; Abergel A; Ollivier-Hourmand I; Gournay J; Ayoub J; Gaborit C; Rusch E; Giraudeau B;
    J Hepatol; 2014 May; 60(5):962-8. PubMed ID: 24480619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
    Wei J; Li H; Li C
    J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation.
    Wils A; van der Linden E; van Hoek B; Pattynama PM
    J Clin Gastroenterol; 2009; 43(10):982-4. PubMed ID: 19417681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.